[go: up one dir, main page]

AU2001266940A1 - Vaccine for congenital tremors in pigs - Google Patents

Vaccine for congenital tremors in pigs

Info

Publication number
AU2001266940A1
AU2001266940A1 AU2001266940A AU6694001A AU2001266940A1 AU 2001266940 A1 AU2001266940 A1 AU 2001266940A1 AU 2001266940 A AU2001266940 A AU 2001266940A AU 6694001 A AU6694001 A AU 6694001A AU 2001266940 A1 AU2001266940 A1 AU 2001266940A1
Authority
AU
Australia
Prior art keywords
pigs
vaccine
congenital tremors
tremors
congenital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266940A
Other languages
English (en)
Inventor
Jiwon Choi
Charles L. Kanitz
Matti Kiupel
Suresh K Mittal
Gregory W. Stevenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of AU2001266940A1 publication Critical patent/AU2001266940A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001266940A 2000-06-15 2001-06-15 Vaccine for congenital tremors in pigs Abandoned AU2001266940A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21171000P 2000-06-15 2000-06-15
US60211710 2000-06-15
PCT/US2001/019220 WO2001096377A2 (fr) 2000-06-15 2001-06-15 Vaccin contre les tremblements congenitaux du porc

Publications (1)

Publication Number Publication Date
AU2001266940A1 true AU2001266940A1 (en) 2001-12-24

Family

ID=22788038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266940A Abandoned AU2001266940A1 (en) 2000-06-15 2001-06-15 Vaccine for congenital tremors in pigs

Country Status (6)

Country Link
EP (1) EP1290016A2 (fr)
JP (1) JP2004503234A (fr)
AU (1) AU2001266940A1 (fr)
CA (1) CA2410229A1 (fr)
MX (1) MXPA02012352A (fr)
WO (1) WO2001096377A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040062775A1 (en) 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
GB0318096D0 (en) * 2003-08-01 2003-09-03 Queen Mary & Westfield College Vaccine
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
DK1833992T3 (da) * 2004-12-30 2015-06-08 Boehringer Ingelheim Vetmed PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US7358075B2 (en) * 2005-04-13 2008-04-15 Merial Limited Assay for porcine circovirus production
TW200643171A (en) * 2005-06-07 2006-12-16 Temasek Life Sciences Lab Ltd Porcine circovirus type 2 vaccines
AU2006330491B2 (en) 2005-12-29 2011-08-18 Boehringer Ingelheim Animal Health USA Inc. Multivalent PCV2 immunogenic compositions and methods of producing such compositions
DK3127551T3 (da) 2005-12-29 2020-10-12 Boehringer Ingelheim Animal Health Usa Inc Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
DK2481420T3 (da) 2006-12-15 2019-05-06 Boehringer Ingelheim Animal Health Usa Inc Enkeltdosis-anti-PCV2-svinevaccine
EP1941903A1 (fr) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxie et traitement du PRDC
EP1958644A1 (fr) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prévention et traitement du PCVD subclinique
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
WO2009093251A2 (fr) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Vaccin contenant un réovirus basé sur une séquence de protéine sigma c
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
HUP1100470A2 (en) * 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
KR102319843B1 (ko) 2013-09-25 2021-10-29 조에티스 서비시즈 엘엘씨 Pcv2b 분지형 백신 조성물 및 사용 방법
EA035265B1 (ru) 2013-10-02 2020-05-21 Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
CN104109704B (zh) * 2014-07-09 2016-05-04 福州大学 一种重组猪圆环病毒衣壳蛋白包涵体的分离纯化方法
WO2017040672A1 (fr) 2015-08-31 2017-03-09 Boehringer Ingelheim Vetmedica Gmbh Vaccins à base de pestivirus pour les tremblements congénitaux
CN111087452A (zh) * 2019-12-18 2020-05-01 中国农业科学院兰州兽医研究所 一种猪圆环病毒2b亚型Cap蛋白的原核可溶性表达方法
CN111154915A (zh) * 2020-01-06 2020-05-15 咸阳职业技术学院 一种猪圆环病毒4型与3型pcr鉴别诊断试剂盒及其检测方法
CN112014561B (zh) * 2020-09-03 2022-04-19 扬州大学 猪圆环病毒4型特异的抗原在制备检测猪圆环病毒4型抗体的试剂盒中的应用及试剂盒
CN120535658B (zh) * 2022-08-18 2025-12-05 山东信达基因科技有限公司 基于pcv4特异性蛋白序列合成的pcv4-c157重组抗原及其在制备抗猪pcv4特异性抗体中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
ES2526760T3 (es) * 1997-12-11 2015-01-15 Merial Virus del síndrome del desmedro multisistémico post-destete procedente de cerdos

Also Published As

Publication number Publication date
CA2410229A1 (fr) 2001-12-20
EP1290016A2 (fr) 2003-03-12
WO2001096377A2 (fr) 2001-12-20
MXPA02012352A (es) 2004-09-06
JP2004503234A (ja) 2004-02-05
WO2001096377A3 (fr) 2002-06-13

Similar Documents

Publication Publication Date Title
AU2001266940A1 (en) Vaccine for congenital tremors in pigs
AU7886301A (en) Transesterification process
GB0020953D0 (en) Vaccine
IL155072A0 (en) Vaccine
IL155282A0 (en) Vaccines
AU2001271592A1 (en) Containment system
AU1591402A (en) Vaccine
AU2001258279A1 (en) Adjuvant for vaccines
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
GB0014288D0 (en) Vaccine
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001231803A1 (en) Method in trade
AU2001234616A1 (en) Vaccine composition, process and methods
AU2001280674A1 (en) Mini-adenoviral vector system for vaccination
IL141376A0 (en) Large group interactions
AU2002221760A1 (en) Vaccine for treating allergy
AU2001267541A1 (en) Vaccine composition
AUPQ726700A0 (en) Containment system
GB0014845D0 (en) Vaccine
AU2001267769A1 (en) Process
GB0025694D0 (en) Vaccine
GB0003082D0 (en) Vaccine
EP1213070A3 (fr) Procédé et dispositif pour la coulée de métal
AU2767201A (en) M cell directed vaccines
GB0015722D0 (en) Vaccine